Company profile
Harbour Biomed company profile
Harbour BioMed is a developer of bio-therapeutics aimed at immuno-oncology and inflammatory diseases. The company engages in discovery and development programs that are centered around two patented transgenic mouse platforms for generating both fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb) based immune cell engager (HBICETM) bispecific antibodies, thereby enabling medical professionals to generate potential therapeutic antibodies and accelerate drug discovery and development.
Business identity
- Contact email
- [email protected]
- Phone number
- +86-21-51370990
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $10M-$100M
- Founded
- 2016-01-01, Year
Headquarters
- Headquarters
- Shaxi, Fujian, China
- Postal code
- 200032
- Country code
- CN
- Continent
- Asia